Introduction
Compounds consisting of the catechol group con nected to an amino acid or a small peptide only re cently have been the subject of few papers concern ing their structure-activity relationship.
A number of 2,3-dihydroxybenzoic acid amides such as polyamine derivatives: parabactin [1 ] , agrobactin [2] , vibriobactin [3] , or amino acid derivatives: glycine [4] , lysine [5] , serine [6 ] , and threonine [7] , as well as depsipeptide enterobactin [8] have been iso lated from bacterial cultures. Due to the powerful ligand potency of catechol groups most of them act as iron carriers of natural origin -siderophores [9] .
However, only two 2,3-dihydroxybenzoyl dipep tides: Ala-Thr [10] and Ala-(N~ -Ac-N~ -OH)Orn [11] have been isolated from microbial fer mentation products. They exhibited inhibitory properties against therapeutically important en zymes: leucine aminopeptidase [EC 3. 4.11.1] [10] and thymidylate synthase [EC 2.1. 1.45 ] [12] respec tively. A variety of redox-active agents, including catechols, exhibit antitumor activity in vitro as well as in vivo [13] . The compounds with 3,4-dihydroxyphenyl groups related to DOPA [14] play the key role among them. A paper reporting catechol-like compounds showing greater potency and selectivity against malignant melanoma than the natural prod uct, L-DOPA methyl ester, has been published re cently [15] . It also appeared that penicillin deriva tives having catechol moieties exhibit up to 30 to 60-fold greater activity in vitro against Gram-negative bacteria [16] .
Results and Discussion
The synthetic iron ligands -analogues of siderophores [17, 19] , and compounds removing plutonium [18] , containing the 2,3-dihydroxybenzoyl group, have been the subject of our studies lately. One of us stated [19] that N-hydroxysuccinimidyl 2,3-dibenzyloxybenzoate is the most advantageous starting materials for those syntheses. Following our synthetic scheme we carried out the first syn thesis of 2,3-dihydroxybenzoyl-L-alanyl-L-threonine (2,3-DHBA-Ala-Thr) (5a), the natural in hibitor of leucine aminopeptidase (LAP), and synth eses of several of their analogues [20] (Table I) .
The synthesized compounds exhibited inhibitory activity towards LAP from hog kidney. The deter mined concentration causing 50% inhibition of en zyme (IC50) was 2.5 to 30 //M for four analogues. 3,4-Dihydroxybenzoyl dipeptides appeared to be inac tive against LAP. Table I shows that the presence of the 2,3-di hydroxybenzoyl moiety is crucial for biological activ ity. Lack of any of these hydroxy groups causes loss of inhibitory properties (5 a ,b ,c ) . The position of alanine as the first amino acid, acylated with 2,3-di hydroxybenzoyl group is also important (5 a ,d ,f, h).
Switching Ala and Thr leads to a 5-fold decrease of activity (comp. 5a and j). Two of the synthesized compounds (5d,f) are more active than the natural inhibitor (5a). We assume that both, the 2,3-dihy droxybenzoyl and carboxylic groups take part in a complex formed with LAP in the active center of this metalloprotease.
Syntheses of the catechoyl-dipeptides D H B A -A a '-A a" (5) have been carried out in two ways: where: Aa' = amino acid; Aa''-OY = amino acid methyl or benzyl ester; Boc = f-butyloxycarbonyl. For introduction of catechoyl residues into amino acid or peptide molecules we propose N-hydroxysuccinimide esters: the already synthesized 2,3-dibenzyloxybenzoic ester (la) [19] and a new 3,4-dibenzyloxy derivative (lb).
In procedure I methyl and benzyl esters of 2,3-dibenzyloxybenzoyldipeptides (4) have been obtained from their r-butyloxy (Boc) derivatives (2) by remov ing the Boc group with trifluoroacetic acid and then acylation using 2,3-dibenzyloxybenzoic acid N-hydroxysuccinimide ester (la).
Procedure II led to the esters of DBBA-dipeptides (4) by acylation of aminoacids with N-hydroxysuccinimide esters (1) and coupling the products 3 with amino acids esters using the method of mixed anhy drides modified by Benoiton [21] to minimize the unwanted racemization of acylating amino acid and to avoid urethane formation.
Hydrogenolysis of the benzyl groups gave the final dihydroxybenzoyl dipeptides 5. The yields of the syntheses and some physical properties of com pounds 4 are given in Table II. Compounds 4 obtained by procedures I or II were identical and chromatographically homogenous after one recrystallization. The products of hydrogenolysis 5 were amorphous and rather sensitive to the air so they should be stored in atmosphere of inert gas.
The products have been characterized by IR. 'H NMR, and MS-FD spectra. They are soluble in water (10-20 mg in 1 ml), particularly at pH = 7, but too high pH values are not recommended as that may promote oxidation reactions. These compounds are also soluble in alcohols, mostly in acetone and ethyl acetate but insoluble in benzene, ether, chloroform, and hexane. They form strong complex es with the ferric ion and these complexing and re ducing properties, resulted from the catechoyl group presence, led us to believe that they inactivate metalloenzyme, such as LAP, and may also inhibit other therapeutically important enzymes. Further investi gations on the subject are in progress.
Experimental
All melting points are uncorrected. IR spectra were recorded in KBr on Zeiss-Jena UR-10 ap paratus, 'H-NMR spectra on the Varian EM-360 A spectrometer. Optical rotation were determined with Carl-Zeiss Polamat A polarimeter.
Chemicals
Leucine aminopeptidase (EC 3.4.11.1) from hog kidney ca. 100 U/mg protein and L-leucine-4-nitroanilide were from Serva, Heidelberg. The follow ing compounds have been synthesized according to published procedures: 2,3-dibenzyloxybenzoic acid N-hydroxysuccinimide ester [19] , L-amino acids es ters [22] , N^-acetyl-L-ornithine benzyl ester [12] , Nr> -benzyloxycarbonyl-L-ornithine benzyl ester hy drochloride [23] .
3,4-D ibenzyloxybenzoic acid N-hydroxysuccinimide ester (lb)
A solution of 3,4-dibenzyloxybenzoic acid (5.0 g, 15 mmol) and N-hydroxysuccinimide (1.73 g, 15 mmol) in 30 ml of DMF was cooled to 0 °C and dicyclohexylcarbodiimide (DCC) (3.7 g, 16 mmol) was added. After standing overnight precipitated urea was filtered off and washed with dioxane. The combined filtrates were poured into cold solution of N aH C03 in water (100 ml), the product was ex tracted with ethyl acetate three times and the solvent evaporated in vacuo. Recrystallization from CHC13/ hexane gave white crystals; yield 5.82 
t-Butyloxycarbonyl-L-alanyl-L-leucine methyl ester (2d)
Yield 67%; m.p. 6 
t-Butyloxycarbonyl-L-alanyl-L-(N5-acetyl)ornithine benzyl ester

t-Bitty loxy carbonyl-L-alanyl-L-(N'-benzy loxycarbonyl)ornithine benzyl ester (2 i)
Yield 8 4 (s, 3xCH,), 1.4-1.7 (m,  2xC H 2), 3.1 (m, CH2), 4.1 and 4.5 (2m. 2xCH) , 4.9 and 5.1 (2s, 2xCH,Ar), 6 .8 
2,3-D ibenzyloxy benzoyl-L-alanine (3a)
Ester la (1.29 g, 3 mmol) was dissolved in CH3CN (50 ml) and a solution of L-alanine (0.45 g, 5 mmol) and NEt3 (1.4 ml, 10 mmol) in 15 ml of water was added dropwise with stirring. The stirring was con tinued until a precipitate dissolved and then the solu tion was left standing for 3 h at room temperature. The solvent was evaporated, 10 ml of water added and a solution washed with AcOEt. The aqueous layer was acidified with hydrochloric acid and the product extracted 4 times with AcOEt. After evap oration and recrystallization from AcOEt/hexane 1.03 g of 3a were obtained (yield 85%); m.p. 
3,4-Dibenzyloxybenzoyl-L-alanine (3 b)
The compound was synthesized from ester l b and L-alanine as above. Recrystallization from warm acetone/ethyl ether; yield 1.17 
2,3-D ibenzyloxybenzoyl-L-threonine (3c)
Procedure as for 3a; yield 75%; m.p. 137-138 °C (lit. [24] : 136-138 °C).
D ibenzyloxybenzoyl dipeptides (4)
General procedure I: 2 mmol of 2 were dissolved in 1 ml of trifluoroacetic acid and left for 30 min at room temp. The acid was evaporated and the crude oil was evaporated several times with dry ethyl ether -until crystals appeared. Then 2 mmol of l a dis solved in 10 ml of CH2C12 and 2 mmol of N-methylmorpholine were added. Progress of the reaction was controlled by TLC (n-Bu0H/pyridine/H20 = 1:1:1 or Ac0Et/M e0H/H20 = 10:3:1 solvent system). After 18-48 h at room temperature the solvent was evaporated, the residue dissolved in 20 ml of AcOEt and washed with 0.5 N HC1, water, 3% N aH C 03, and water. It was next dried over MgS04, the solvent evaporated again and the product subjected to re crystallization. Yield of pure products: 67-90%. Compounds 4d and 4f were obtained by hydrolysis of the corresponding methyl esters with 1 N NaOH.
General procedure II:
To the solution of 1.05 mmol of 3, obtained as above, in 4 ml of CH2C12 N-methylmorpholine (0.11 ml; 1 mmol) was added. The solution was cooled to -15 °C, isobutyl chloroformate (0.134 ml; 1 mmol) added, and after a 1 min activation at this temperature 1 .2 mmol of amino acid ester hydrochloride and N-methylmor pholine (0.132 ml; 1.2 mmol) in 2 ml of CH2C12 were added and left to stand for 15 h at room tempera ture. The work-up was carried out as in procedure I. Yield of pure compounds 4: 54-98%.
Compounds 4d, 4f, 4j were obtained after hy drolysis of corresponding methyl esters.
Yields and physical data of compounds 4 are given in Table II, while Table III and IV present their analytical and spectral data. The other data are given in Table II .
The estimation o f enzym e activity
Compounds 5 were tested as inhibitors of leucine aminopeptidase from hog kidney. The standard incu bation mixture contained: 1.6 mmol of L-leucine-4-nitroanilide, 100 jug of the enzyme, and a potential inhibitor at appropriate concentration in the total volume of 2 ml. The mixtures were incubated for 30 min at 37 °C and then absorbances at 420 nm were measured. Concentrations of inhibitors causing 50% inhibition of the enzyme (IC5n) were read from curves representing dependance of percentage of en zyme activity versus inhibitor concentrations.
